Janux Therapeutics (JANX) Cash & Equivalents (2020 - 2026)
Janux Therapeutics (JANX) recorded Cash & Equivalents of $27.77 million in Q2 2026, down 47.1% from $52.45 million a year earlier and down 46.4% from the prior quarter.
Powered by 
Analysis
Janux Therapeutics (JANX) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Janux Therapeutics reported Cash & Equivalents of $52.33 million, down 87.8% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 46.3% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $430.61 million in FY2024, $19.21 million in FY2023 (-62.7%), $51.43 million in FY2022 (+44.5%) and $35.58 million in FY2021 (+355.4%).
- The Q2 2026 figure is the lowest quarterly Cash & Equivalents since Q3 2024.
- On a year-over-year basis, Cash & Equivalents has declined for three consecutive quarters, with growth averaging 23.5% over the last seven quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 601.0% in Q1 2024, against a decline of 87.8% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $51.83 million (Q1 2026), $52.33 million (Q4 2025) and $48.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Janux Therapeutics | 1.04 Bn | 1.04 Bn | - | 27.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.77 Mn |
| Mar 31, 2026 | 51.83 Mn |
| Dec 31, 2025 | 52.33 Mn |
| Sep 30, 2025 | 48.39 Mn |
| Jun 30, 2025 | 52.45 Mn |
| Mar 31, 2025 | 73.74 Mn |
| Dec 31, 2024 | 430.61 Mn |
| Sep 30, 2024 | 26.75 Mn |
| Jun 30, 2024 | 14.66 Mn |
| Mar 31, 2024 | 212.80 Mn |
| Dec 31, 2023 | 19.21 Mn |
| Sep 30, 2023 | 17.15 Mn |
| Jun 30, 2023 | 33.70 Mn |
| Mar 31, 2023 | 30.36 Mn |
| Dec 31, 2022 | 51.43 Mn |
| Sep 30, 2022 | 64.75 Mn |
| Jun 30, 2022 | 58.40 Mn |
| Mar 31, 2022 | 55.13 Mn |
| Dec 31, 2021 | 35.58 Mn |
| Sep 30, 2021 | 39.39 Mn |
API Access
Janux Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=JANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "JANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=JANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();